Alaleh Nouri is EVP, CLO, CORP. SEC. of PROCEPT BioRobotics Corp. Currently has a direct ownership of 62,472 shares of PRCT, which is worth approximately $4.15 Million. The most recent transaction as insider was on Dec 16, 2022, when has been sold 20,000 shares (Common Stock) at a price of $41.97 per share, resulting in proceeds of $839,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.5K
31.93% 3M change
33.11% 12M change
Total Value Held $4.15 Million

Alaleh Nouri Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2022
SELL
Open market or private sale
$839,400 $41.97 p/Share
20,000 Reduced 42.44%
27,126 Common Stock
May 16 2022
SELL
Open market or private sale
$23,771 $35.06 p/Share
678 Reduced 1.44%
46,468 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$100,010 $29.38 p/Share
3,404 Added 6.83%
46,468 Common Stock
AN

Alaleh Nouri

EVP, CLO, CORP. SEC.
Redwood City, CA

Track Institutional and Insider Activities on PRCT

Follow PROCEPT BioRobotics Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

News

Receive news related to PROCEPT BioRobotics Corp

Track Activities on PRCT